CorVel Co. (NASDAQ:CRVL) major shareholder Corstar Holdings Inc sold 4,741 shares of the firm’s stock in a transaction that occurred on Friday, August 24th. The stock was sold at an average price of $60.30, for a total transaction of $285,882.30. Following the transaction, the insider now owns 7,121,322 shares of the company’s stock, valued at approximately $429,415,716.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Corstar Holdings Inc also recently made the following trade(s):

  • On Friday, June 15th, Corstar Holdings Inc sold 30,985 shares of CorVel stock. The stock was sold at an average price of $51.53, for a total transaction of $1,596,657.05.
  • On Monday, June 11th, Corstar Holdings Inc sold 17,584 shares of CorVel stock. The stock was sold at an average price of $52.01, for a total transaction of $914,543.84.
  • On Tuesday, June 5th, Corstar Holdings Inc sold 10 shares of CorVel stock. The stock was sold at an average price of $52.00, for a total transaction of $520.00.
  • On Thursday, June 7th, Corstar Holdings Inc sold 2,009 shares of CorVel stock. The stock was sold at an average price of $52.09, for a total transaction of $104,648.81.

NASDAQ:CRVL opened at $60.30 on Wednesday. The firm has a market capitalization of $1.14 billion, a PE ratio of 29.63 and a beta of 0.66. CorVel Co. has a twelve month low of $46.45 and a twelve month high of $61.20.

CorVel (NASDAQ:CRVL) last released its quarterly earnings data on Tuesday, July 31st. The business services provider reported $0.62 earnings per share for the quarter. The company had revenue of $150.40 million during the quarter. CorVel had a net margin of 6.78% and a return on equity of 23.42%.

Separately, BidaskClub upgraded shares of CorVel from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 7th.

Large investors have recently added to or reduced their stakes in the company. Piedmont Investment Advisors LLC bought a new stake in shares of CorVel in the 2nd quarter valued at $121,000. SG Americas Securities LLC increased its stake in shares of CorVel by 66.0% in the 2nd quarter. SG Americas Securities LLC now owns 3,446 shares of the business services provider’s stock valued at $186,000 after acquiring an additional 1,370 shares in the last quarter. MetLife Investment Advisors LLC bought a new stake in shares of CorVel in the 4th quarter valued at $282,000. Barclays PLC increased its stake in shares of CorVel by 60.8% in the 1st quarter. Barclays PLC now owns 6,231 shares of the business services provider’s stock valued at $315,000 after acquiring an additional 2,355 shares in the last quarter. Finally, Eqis Capital Management Inc. bought a new stake in shares of CorVel in the 2nd quarter valued at $437,000. Institutional investors own 44.84% of the company’s stock.

CorVel Company Profile

CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.

Featured Story: Asset Allocation Models, Which is Right For You?

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.